Flaherty L - Search Results

1

Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934).

LoRusso P, Foster BJ, Poplin E, McCormick J, Kraut M, Flaherty L, Heilbrun LK, Valdivieso M, Baker L. LoRusso P, et al. Among authors: flaherty l. Clin Cancer Res. 1995 Dec;1(12):1487-93. Clin Cancer Res. 1995. PMID: 9815948 Clinical Trial.

2

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.

Poplin EA, Corbett T, Flaherty L, Tarasoff P, Redman BG, Valdivieso M, Baker L. Poplin EA, et al. Among authors: flaherty l. Invest New Drugs. 1992 Aug;10(3):165-70. doi: 10.1007/BF00877241. Invest New Drugs. 1992. PMID: 1428726 Clinical Trial.

3

Effect of calcium replacement on the hemodynamic changes associated with high dose interleukin-2 therapy.

Redman BG, Flaherty L, Martino S, Kraut M, Wisniewski C, Valdivieso M, Bander JJ. Redman BG, et al. Among authors: flaherty l. Am J Clin Oncol. 1992 Aug;15(4):340-3. doi: 10.1097/00000421-199208000-00014. Am J Clin Oncol. 1992. PMID: 1514532 Clinical Trial.

4

Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancer.

Redman BG, Flaherty L, Chou TH, Kraut M, Martino S, Simon M, Valdivieso M, Groves E. Redman BG, et al. Among authors: flaherty l. J Immunother (1991). 1992 Jul;12(1):50-4. doi: 10.1097/00002371-199207000-00006. J Immunother (1991). 1992. PMID: 1637782 Clinical Trial.

5

5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.

Flaherty L, Wozniak A, Redman B, Kraut M, Martino S, Heilbrun L, Valdivieso M. Flaherty L, et al. Cancer. 1991 Sep 1;68(5):944-7. doi: 10.1002/1097-0142(19910901)68:5<944::aid-cncr2820680506>3.0.co;2-g. Cancer. 1991. PMID: 1655218 Clinical Trial.

6

SWOG 8825: melphalan GM-CSF: a phase I study.

Poplin E, Smith H, Behrens B, Redman B, Flaherty L, Neidhart J, Alberts D. Poplin E, et al. Among authors: flaherty l. Gynecol Oncol. 1992 Jan;44(1):66-70. doi: 10.1016/0090-8258(92)90014-a. Gynecol Oncol. 1992. PMID: 1730428 Clinical Trial.

7

Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.

Martino S, Samal BA, Redman B, Flaherty L, Kraut M, Simon M, Valdivieso M. Martino S, et al. Among authors: flaherty l. Breast Cancer Res Treat. 1990 Dec;17(2):139-43. doi: 10.1007/BF01806294. Breast Cancer Res Treat. 1990. PMID: 2096991 Clinical Trial.

8

Scintigraphic findings in patients with shoulder pain caused by interleukin-2.

Baron NW, Davis LP, Flaherty LE, Muz J, Valdivieso M, Kling GA. Baron NW, et al. Among authors: flaherty le. AJR Am J Roentgenol. 1990 Feb;154(2):327-30. doi: 10.2214/ajr.154.2.2105025. AJR Am J Roentgenol. 1990. PMID: 2105025

9

A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancer.

Redman BG, Flaherty L, Chou TH, al-Katib A, Kraut M, Martino S, Chen B, Kaplan J, Valdivieso M. Redman BG, et al. Among authors: flaherty l. J Clin Oncol. 1990 Jul;8(7):1269-76. doi: 10.1200/JCO.1990.8.7.1269. J Clin Oncol. 1990. PMID: 2113571

10

Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients.

Chabot GG, Flaherty LE, Valdivieso M, Baker LH. Chabot GG, et al. Among authors: flaherty le. Cancer Chemother Pharmacol. 1990;27(2):157-60. doi: 10.1007/BF00689102. Cancer Chemother Pharmacol. 1990. PMID: 2249333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters